HS Code:
Aminoguanidine bicarbonate (CAS No. 2582-30-1), classified under HS Code 2928.00.50, is an organic chemical compound used primarily as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other industrial chemicals. It is particularly significant in the production of drugs for diabetes treatment and as a stabilizer in certain chemical processes. This compound falls under the broader category of other organic compounds containing nitrogen, and its trade is influenced by demand in the pharmaceutical and chemical industries.
Total Trade Volume
Approximately $50 million USD
Data from 2022
Source
United Nations Comtrade Database, International Trade Centre (ITC)
$20 million USD
40% of total trade of total trade
Increasing
$10 million USD
20% of total trade of total trade
Increasing
$8 million USD
16% of total trade of total trade
Stable
$5 million USD
10% of total trade of total trade
Stable
$3 million USD
6% of total trade of total trade
Decreasing
Average Rate
5.5% ad valorem
Highest Rate
10% (applied by certain developing countries)
Lowest Rate
0% (under free trade agreements like EU-Japan EPA)
Rising demand in pharmaceutical applications
Increased production and export from major suppliers like China and India due to growing need for diabetes treatment drugs.
2021-2022
Stringent environmental regulations
Higher compliance costs for manufacturers, leading to slight price increases and shifts in supply chains to countries with laxer regulations.
2020-2022
Technological advancements in synthesis
Improved production efficiency in developed countries like the US and Germany, potentially reducing dependency on imports from Asia.
2019-2022
The European Union updated its REACH regulations, requiring more rigorous safety data for imports of Aminoguanidine bicarbonate, affecting exporters from non-EU countries.
June 2023
Potential delays in shipments and increased costs for exporters to the EU market.
A new phase of trade negotiations between the US and China includes discussions on reducing tariffs for certain chemical intermediates, including Aminoguanidine bicarbonate.
March 2023
Could lead to increased trade volume between the two countries if tariffs are lowered.
The Indian government introduced subsidies for local production of pharmaceutical intermediates, including Aminoguanidine bicarbonate, to reduce reliance on imports.
January 2023
Likely to increase India's export share while reducing import dependency.